NUTRALIFE BIOSCIENCES, INC - FORM 10-Q/A - EX-31.2 - EXHIBIT 31.2 - November 19, 2014

Attached files

file filename
EX-10.19 - AMENDED NOTE TO AUGUST 26, 2013 NOTE BETWEEN NUTRAFUELS, INC. AND CRAIG HETHERINGTON - NUTRALIFE BIOSCIENCES, INCf1019craighetherington200kam.htm
EX-10.17 - AMENDED NOTE TO FEBRUARY 15, 2013 NOTE BETWEEN NUTRAFUELS, INC. AND NEAL CATANIA - NUTRALIFE BIOSCIENCES, INCf1017neilcatania50000amended.htm
EXCEL - IDEA: XBRL DOCUMENT - NUTRALIFE BIOSCIENCES, INCFinancial_Report.xls
EX-31.1 - EXHIBIT 31.1 - NUTRALIFE BIOSCIENCES, INCexhibit311.htm
EX-10.20 - AMENDED NOTE TO NOVEMBER 15, 2012 NOTE BETWEEN NUTRAFUELS, INC. AND MICHAEL SMYTH - NUTRALIFE BIOSCIENCES, INCf1020mikesmyth50kamendedandr.htm
10-Q/A - FORM 10-Q/A - NUTRALIFE BIOSCIENCES, INCf10qforquarterended93014docx.htm
EX-10.18 - AMENDED NOTE TO NOVEMBER 15, 2012 NOTE BETWEEN NUTRAFUELS, INC. AND NEAL CATANIA - NUTRALIFE BIOSCIENCES, INCf1018neilcatania160000amende.htm
EX-10.21 - NOTE AGREEMENT DATED OCTOBER 2, 2014, BETWEEN NUTAFUELS AND JOHN HAMPTON - NUTRALIFE BIOSCIENCES, INCf1021convertiblenotenutra60k.htm

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of NutraFuels, Inc., (the “Company”) on Form 10-Q for the period ended September 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Edgar Ward, Chief Executive Officer of the Company, certifies, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:

 

(1)  

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)  

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

Dated: November 19, 2014

By:

/s/ Edgar Ward

 

 

Edgar Ward

 

 

Chief Executive Officer

 

 

(Principal Executive Officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 




NUTRALIFE BIOSCIENCES, INC Reports